Getting a routine blood panel back showing 'normal' vitamin D levels while still feeling exhausted, achy, and foggy is one of the more frustrating experiences of perimenopause. What nobody mentioned was that 'normal' ranges were never calibrated with menopausal physiology in mind — and that the threshold for optimal might sit quite a bit higher than the lab's reference range suggests.
Learn more about Rose →Estrogen receptors and vitamin D receptors are functionally linked — estrogen upregulates the expression of vitamin D receptors (VDRs) in tissues including the gut, bone, and brain. When estrogen levels drop in menopause, VDR expression decreases, meaning the body becomes less responsive to the vitamin D that is circulating. The same serum level of vitamin D that was adequate before menopause may no longer produce the same biological effect.
Before menopause, estrogen supports calcium absorption through a partly vitamin D-independent pathway in the intestinal lining. After menopause, that estrogen-driven pathway closes down, and the body shifts to relying almost entirely on calcitriol — the active form of vitamin D — to pull calcium across the gut wall. This means that even a modest shortfall in vitamin D has a disproportionately large effect on calcium absorption in postmenopausal women compared to premenopausal women.
The conversion of 25-hydroxyvitamin D (the storage form measured in blood tests) to calcitriol (the active form) happens primarily in the kidneys and requires adequate renal function. Kidney efficiency declines with age, and emerging research suggests estrogen also plays a role in supporting this conversion step. Menopausal women may therefore have acceptable 25-hydroxyvitamin D levels on paper while still producing insufficient calcitriol to meet physiological demand.
In the first five to seven years after menopause, bone turnover accelerates dramatically — osteoclasts (cells that break down bone) become more active relative to osteoblasts (cells that build bone). Vitamin D is required not only to supply calcium to bone but to modulate the signaling between these two cell types. Higher circulating calcitriol is needed to keep pace with this accelerated remodeling cycle, raising the functional requirement well above what a standard maintenance dose provides.
Vitamin D is fat-soluble, meaning it is stored in adipose tissue and released back into the bloodstream over time. The redistribution of body fat that typically accompanies menopause — from peripheral to central and visceral storage — appears to affect this sequestration and release dynamic. Visceral fat may sequester vitamin D more effectively than subcutaneous fat, reducing the amount available for active use and creating a functional deficit even when total body stores appear adequate.
The Institute of Medicine's oft-cited Recommended Dietary Allowance of 600 IU for adults aged 19–70 was calculated to maintain bone health in the general adult population and was not designed to account for the hormonal context of menopause. Multiple endocrinology and menopause specialist bodies, including the Menopause Society, have noted that 1,500–2,000 IU daily may be more appropriate for postmenopausal women not on hormone therapy. The 600 IU figure is a population floor, not a menopausal optimum.
Vitamin D receptors are widely distributed throughout the brain, including in regions involved in mood regulation and memory consolidation such as the hippocampus and prefrontal cortex. Low vitamin D levels have been independently associated with increased rates of depression and cognitive complaints — symptoms that also overlap heavily with perimenopause. In women already navigating estrogen-related brain changes, a concurrent vitamin D shortfall can make mood instability and brain fog substantially harder to distinguish and manage.
Vitamin D acts on muscle tissue through VDRs to support strength, coordination, and reaction time — all of which decline with both aging and the loss of estrogen's protective effect on muscle. Clinical trials have shown that vitamin D supplementation at doses above 800 IU reduces fall risk in older adults, with the greatest benefit seen in those who were deficient at baseline. Because menopausal women face simultaneous losses in estrogen and potentially in vitamin D responsiveness, muscle-related protection requires closer attention to achieving optimal rather than merely sufficient levels.
Standard blood tests measure 25-hydroxyvitamin D, the storage precursor, but do not directly measure calcitriol or VDR responsiveness — the factors most relevant to whether vitamin D is actually working in menopausal tissues. Some researchers argue that optimal serum levels for menopausal women may sit between 40–60 ng/mL (100–150 nmol/L), considerably above the 20 ng/mL threshold widely used to define sufficiency in the general population. A woman can be told her vitamin D is fine while her tissues are functionally under-served, which is why testing context and interpretation matter as much as the number itself.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.